Home > Financial Ratios > SHREE GANESH REMEDIES

SHREE GANESH REMEDIES
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for SHREE GANESH REMEDIES
Please provide your vote to see the results

SHREE GANESH REMEDIES Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2020Mar2019
   EV/Core EBITDA(x) 19.544.094.88

What is the latest EV/Core EBITDA ratio of SHREE GANESH REMEDIES ?

The latest EV/Core EBITDA ratio of SHREE GANESH REMEDIES is 19.54 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202419.54
Mar20204.09
Mar20194.88

How is EV/Core EBITDA of SHREE GANESH REMEDIES Trending?

Years EV/Core EBITDA % Change
Mar2024 19.54
377.75
Mar2020 4.09
-16.19
Mar2019 4.88 -

Other Financial Ratios of SHREE GANESH REMEDIES


Compare EV/Core EBITDA ratio of peers of SHREE GANESH REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SHREE GANESH REMEDIES ₹793.2 Cr 1.8% -13.3% -15.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹403,076.0 Cr 0.3% -4.9% 15.8% Stock Analytics
DIVIS LABORATORIES ₹173,924.0 Cr 0.2% 10% 53.5% Stock Analytics
CIPLA ₹121,456.0 Cr 2.3% 1.1% 2.6% Stock Analytics
DR REDDYS LABORATORIES ₹110,197.0 Cr 5.7% 15% 11.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹106,761.0 Cr 0.8% -0.9% 17.4% Stock Analytics


SHREE GANESH REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SHREE GANESH REMEDIES

1.8%

-13.3%

-15.6%

SENSEX

0.9%

1.8%

11.1%


You may also like the below Video Courses